Algert Global’s HilleVax HLVX Stock Holding History

Algert Global’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-35,884	Closed	-$519K	–	1356
2024 Q2	$519K	Buy	+35,884	New	+$493K	0.02%	902

Other funds holding HLVX

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Algert Global's HLVX Position: Q3 2024 in Review

Algert Global sold out of HilleVax (HLVX) in Q3 2024, closing a stake of 35,884 shares — an estimated $519K sold.

Algert Global first reported a position in HLVX in Q2 2024 and held it in 1 quarter. The position peaked at $519K in Q2 2024. 79 funds tracked by Wall St. Rank hold HLVX as of Q3 2024.

Algert Global reported no remaining HilleVax position as of Q3 2024 after selling out during the quarter.
Algert Global sold 35,884 HilleVax shares in Q3 2024, an estimated $519K.
Algert Global first reported a position in HilleVax in Q2 2024 and held it in 1 quarter.
Algert Global's HilleVax position peaked at $519K in Q2 2024.
79 funds tracked by Wall St. Rank held HilleVax as of Q3 2024.

Based on Algert Global's 13F filing for Q3 2024, filed 12 Nov 2024.